Bronchoalveolar lavage in sarcoidosis
- PMID: 17975776
- DOI: 10.1055/s-2007-991521
Bronchoalveolar lavage in sarcoidosis
Abstract
There is no single cell type present in bronchoalveolar lavage (BAL) fluid that appears to be predictive for sarcoidosis. However, BAL fluid analysis can be very helpful in the differential diagnosis. A grouping of features, an elevated total cell count, predominantly lymphocytes, together with a nearly normal percentage of eosinophils and polymorphonuclear neutrophils and the absence of plasma cells, distinguish the most likely diagnosis of sarcoidosis from the most common interstitial lung diseases, extrinsic allergic alveolitis (EAA), nonspecific interstitial pneumonia (NSIP), and idiopathic pulmonary fibrosis (IPF). In sarcoidosis the majority of cases have an increased number of lymphocytes and a normal amount of eosinophils and neutrophils. Disease presentation or activity at the time the BAL is performed as well as the smoking status is crucial for interpretation of individual BAL fluid analysis results. In severe cases the number of neutrophils can be increased as well. For an individual case the CD4:CD8 ratio is of less importance because it can be increased, normal, and even decreased. In the follow-up depicting prognosis and response to treatment, BAL fluid analysis has less clinical relevance.
Similar articles
-
[Lymphocyte populations in bronchoalveolar lavage fluid in various interstitial lung diseases].Z Erkr Atmungsorgane. 1984;163(2):140-5. Z Erkr Atmungsorgane. 1984. PMID: 6506803 German.
-
[Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].Pneumologie. 2003 Apr;57(4):202-7. doi: 10.1055/s-2003-38569. Pneumologie. 2003. PMID: 12690558 German.
-
Bronchoalveolar lavage in idiopathic pulmonary fibrosis: what does it tell us?Respir Med. 2010 Jul;104 Suppl 1:S70-3. doi: 10.1016/j.rmed.2010.03.019. Epub 2010 May 14. Respir Med. 2010. PMID: 20471812
-
BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.Diagn Cytopathol. 2008 Dec;36(12):909-15. doi: 10.1002/dc.20944. Diagn Cytopathol. 2008. PMID: 18855907 Review.
-
Bronchoalveolar lavage in idiopathic interstitial lung diseases.Semin Respir Crit Care Med. 2007 Oct;28(5):496-503. doi: 10.1055/s-2007-991522. Semin Respir Crit Care Med. 2007. PMID: 17975777 Review.
Cited by
-
Pulmonary granulomatosis of genetic origin.Eur Respir Rev. 2021 Apr 29;30(160):200152. doi: 10.1183/16000617.0152-2020. Print 2021 Jun 30. Eur Respir Rev. 2021. PMID: 33927005 Free PMC article. Review.
-
Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease.Clin Exp Immunol. 2009 Mar;155(3):559-66. doi: 10.1111/j.1365-2249.2008.03791.x. Epub 2008 Dec 9. Clin Exp Immunol. 2009. PMID: 19077082 Free PMC article.
-
A young man with transitory hemiparesis and lung infiltrates.Breathe (Sheff). 2021 Dec;17(4):210069. doi: 10.1183/20734735.0069-2021. Breathe (Sheff). 2021. PMID: 35035563 Free PMC article.
-
Therapeutic granulocyte and monocyte apheresis (GMA) for treatment refractory sarcoidosis: a pilot study of clinical effects and possible mechanisms of action.Clin Exp Immunol. 2014 Sep;177(3):712-9. doi: 10.1111/cei.12360. Clin Exp Immunol. 2014. PMID: 24773420 Free PMC article.
-
Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Löfgren's syndrome and other sarcoidosis.Clin Exp Immunol. 2019 May;196(2):249-258. doi: 10.1111/cei.13257. Epub 2019 Jan 24. Clin Exp Immunol. 2019. PMID: 30585624 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials